Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sweet

Showing results (281-290 of 322) with videos related to

Pageof 33
Sort By:
Bone Marrow Transplantation|June 1, 1995
Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancerA A Ross, G W Miller, T J Moss, et al.
Obstetrics and Gynecology|October 2, 2004
Bacterial vaginosis and risk of pelvic inflammatory diseaseRoberta B Ness, Sharon L Hillier, Kevin E Kip, et al.
Annals of Hematology|September 7, 2024
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemiaAkriti G Jain, Virginia O Volpe, Chen Wang, et al.
American Journal of Surgery|May 31, 1988
Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infectionsR L Sweet, S A Gall, R S Gibbs, et al.
American Journal of Epidemiology|January 6, 2005
Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk womenRoberta B Ness, Sharon L Hillier, Kevin E Kip, et al.
Leukemia|July 31, 2020
Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML)Seongseok Yun, Susan M Geyer, Rami S Komrokji, et al.
Cancer|July 1, 1979
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatmentU Mintz, J B Miller, H M Golomb, et al.
Leukemia Research|April 29, 2019
A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS)David A Sallman, Rami S Komrokji, Kendra L Sweet, et al.
Annals of Internal Medicine|June 1, 1980
Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphomaD L Sweet, H M Golomb, J E Ultmann, et al.
American Journal of Obstetrics and Gynecology|March 1, 1997
Oral contraception and the recognition of endometritisR B Ness, L M Keder, D E Soper, et al.
Pageof 33

Showing results (281-290 of 322) with videos related to

Sort By:
Pageof 33
Bone Marrow Transplantation|June 1, 1995
Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancerA A Ross, G W Miller, T J Moss, et al.
Obstetrics and Gynecology|October 2, 2004
Bacterial vaginosis and risk of pelvic inflammatory diseaseRoberta B Ness, Sharon L Hillier, Kevin E Kip, et al.
Annals of Hematology|September 7, 2024
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemiaAkriti G Jain, Virginia O Volpe, Chen Wang, et al.
American Journal of Surgery|May 31, 1988
Multicenter clinical trials comparing cefotetan with moxalactam or cefoxitin as therapy for obstetric and gynecologic infectionsR L Sweet, S A Gall, R S Gibbs, et al.
American Journal of Epidemiology|January 6, 2005
Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk womenRoberta B Ness, Sharon L Hillier, Kevin E Kip, et al.
Leukemia|July 31, 2020
Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML)Seongseok Yun, Susan M Geyer, Rami S Komrokji, et al.
Cancer|July 1, 1979
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatmentU Mintz, J B Miller, H M Golomb, et al.
Leukemia Research|April 29, 2019
A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS)David A Sallman, Rami S Komrokji, Kendra L Sweet, et al.
Annals of Internal Medicine|June 1, 1980
Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphomaD L Sweet, H M Golomb, J E Ultmann, et al.
American Journal of Obstetrics and Gynecology|March 1, 1997
Oral contraception and the recognition of endometritisR B Ness, L M Keder, D E Soper, et al.
Pageof 33